US-based Eli Lilly's Kisunla drug and Japanese company Eisai's Leqembi (below), two breakthrough drugs for the diagnosis and ...
Study Finds on MSN3d
Researchers uncover serious flaw in promising Alzheimer’s blood testsNew research reveals concerns over the Alzheimer's blood test accuracy, highlighting phosphorylated tau proteins in ALS ...
Glial fibrillary acidic protein (GFAP) levels peak around 24 hours after traumatic brain injury (TBI) 2. Higher GFAP levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback